Aliso Viejo-based Valeant Pharmaceuticals International has sold patents related to DNA to a Seattle-area biotechnology company.
Bothell, Wash.-based MDRNA Inc., a developer of drugs to fight cancer and other diseases, bought the patents from Valeant for an undisclosed price.
MDRNA is developing drugs that are capable of stopping the action of genes that are linked to certain diseases.
The patents MDRNA bought from Valeant gave it “considerable breadth” in the research and development of nucleic-acid based therapies, the company said in a statement.
The deal is the latest in a series by Valeant, which makes skin, neurology, antiviral and generic drugs.
Last week, Valeant said it was buying an undisclosed Brazilian drug maker and plant.
